Sana Biotechnology
Pascal Beauchesne currently serves as the Executive Director of Cell Therapy Process Development at Sana Biotechnology, Inc., a position held since December 2018, with prior roles including Senior Director and Principal Scientist. From December 2013 to December 2018, Pascal worked at Juno Therapeutics, Inc. as Principal Scientist and contributed to Technology R&D in the capacity of Senior Scientist. Earlier experience includes a Scientist role at Dendreon from January 2011 to November 2013 and a Chemical Engineer position at i-STAT (now Abbott Point of Care Inc.) from May 2002 to April 2003. Pascal holds a PhD in Chemical and Biological Engineering from The University of British Columbia, attained between 2003 and 2012, and holds dual bachelor's degrees in Biochemistry and Chemical Engineering from the University of Ottawa, completed in 2001.
This person is not in the org chart
This person is not in any teams
Sana Biotechnology
2 followers
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy.